|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
September 15, 2000
|
MGH
Vital Signs: FY 2000 third-quarter results A quarterly status report of hospital performance Financial overview: The hospital's strong rebound from last year's operating loss continued in the third quarter, leading the MGH to report an operating gain of $35.1 million year-to-date. Net patient service revenue was $30 million better than budget, as a result of the hard work of employees who have been managing high volume in both inpatient and outpatient areas. Indirect research produced a $1.5 million favorable variance in the third quarter and $33.1 million year-to-date, mainly from growth in research activity and positive negotiations with the National Institutes of Health. Revenue growth outpaced expense increases in the third quarter. Admissions remained very strong in the third quarter, favorable by 1,765 while obersvations stays were below budget by 835. Total inpatient activity remained well above budgeted levels.
Length of stay (LOS) was slightly above budget at 5.93 days, compared with a budget of 5.90 days. The hospital continues to focus on reducing LOS for the remainder of 2000 and moving into 2001.
Average daily census was above budget by 40.
Outpatient visits have been strong throughout FY '00, with volume remaining well above budget and FY '99 levels. Ancillary revenues continue to grow and remain a key driver of outpatient net revenue.
General Hospital financial statement (in millions)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Return to the September 15 table of contents |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||